What is the NOAEL for Erucamide?
Erucamide has 15 NOAEL studies in the database. The lowest reported value is 2.8 mg/L via Inhalation. Source: NTP ICE acute inhalation.
Also known as: (13Z)-13-Docosenamide, FATTY AMIDE-ERUCAMIDE, EINECS 204-009-2, Erucylamide, UNII-0V89VY25BN (+2 more)
CAS 112-84-5
Erucamide (CAS 112-84-5) is a chemical substance. Key regulatory status: REACH registered, 5 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, AICIS, ECHA REACH.
CAS, identifiers, formula, and alternate names for the matched substance record.
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| Europe; plastic_additive | European Chemicals Agency | European Chemicals Agency (ECHA) |
| drinking_water; Europe; manufacturing; plastic_additive | Belgaqua | CPCat |
| Indirect additives food contact (10/2018) | FDA | United States Food and Drug Administration (FDA) |
| detected; Europe; Other indirect contact consumer goods | Danish Environmental Protection Agency | Danish EPA |
| detected; emissions; Europe; Other indirect contact consumer goods; water | Danish Environmental Protection Agency | Danish EPA |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| =43.73 | mg/m3 | DNEL systemic | inhalation | Human | ToxValDB GESTIS DNEL |
| =176 | mg/m3 | DNEL systemic | inhalation | Human | ToxValDB GESTIS DNEL |
| 0V89VY25BN | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| >2.8 | mg/L | LC50 | Inhalation | - | NTP ICE acute inhalation |
| >2500 | mg/kg bw | LD50 | oral | Rat | NTP ICE acute oral |
| >=1000 | mg/kg bw/day | NOAEL | oral | Rat | ECHA |
| =1.000e+4 | ppm | NOAEL | oral | Rat | ECHA |
| =1.000e+5 | ppm | NOAEL | oral | Rat | ECHA |
| 86.7 | % | Viability | Dermal | - | NTP ICE skin irritation |
| 97.85 | % | Viability | Dermal | - | NTP ICE skin irritation |
| 100 | % | Viability | Dermal | - | NTP ICE skin irritation |
| 102.8 | % | Viability | Dermal | - | NTP ICE skin irritation |
| 124 | % | Viability | Dermal | - | NTP ICE skin irritation |
| 105.6 | % | Viability (18 hours) | Dermal | - | NTP ICE skin irritation |
| 70.6 | % | Viability (42 hours) | Dermal | - | NTP ICE skin irritation |
Showing 15 of 15 studies
Registration status from the ECHA REACH registered substances database.
| Status | Name | EC Number | Link |
|---|---|---|---|
| Registered | (Z)-docos-13-enamide | 204-009-2 | ECHA overview → |
Australian industrial chemicals inventory status and applicable conditions.
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
Erucamide has 15 NOAEL studies in the database. The lowest reported value is 2.8 mg/L via Inhalation. Source: NTP ICE acute inhalation.
Erucamide appears on 5 regulatory/inventory lists including Europe; plastic_additive, drinking_water; Europe; manufacturing; plastic_additive, Indirect additives food contact (10/2018), and 2 more. Source: EPA CPDat.
Yes, Erucamide is also indexed as a cosmetic ingredient under the name Erucamide. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, ECHA REACH, CosIng / Ingredients DB, ChEMBL / DailyMed. All data traces to primary regulatory sources and is updated from official government databases.
Erucamide also appears in cosmetics, pharmaceutical databases.